InvestorsHub Logo
Followers 22
Posts 1671
Boards Moderated 0
Alias Born 12/12/2006

Re: Rhew123 post# 199

Wednesday, 11/23/2016 6:17:59 PM

Wednesday, November 23, 2016 6:17:59 PM

Post# of 438
It is under accumulation with uptrend back to $8+ support area.

A sharp breakout likely when Entyce drug is launched early 2017. Big catalyst. I expect 1q17 cc to be pivotal for the company unless they ink another deal with Elanco or someone else before than.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.